EAACI Congress 2024
รายงานการพัฒนาล่าสุดในด้านโรคภูมิแพ้และภูมิคุ้มกันวิทยาทางคลินิกที่ EAACI Congress 2024 ในเมืองบาเลนเซีย ประเทศสเปน http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 บาเลนเซีย, สเปน, March 19, 2024 (GLOBE NEWSWIRE) -- European Academy of Allergy and Clinical Immunology...
EAACI Congress 2024
Fique a par dos últimos desenvolvimentos nas áreas da Alergologia e Imunologia Clínica no Congresso da EAACI de 2024 em Valência, Espanha http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 VALÊNCIA, Espanha, March 19, 2024 (GLOBE NEWSWIRE) -- A Academia Europeia de Alergia e Imunologia...
EAACI Congress 2024
Meliputi Perkembangan Terkini Alergi dan Imunologi Klinikal di Kongres EAACI 2024 di Valencia, Sepanyol http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 VALENCIA, Sepanyol, March 19, 2024 (GLOBE NEWSWIRE) -- Akademi Alergi dan Imunologi Klinikal Eropah...
EAACI Congress 2024
アレルギーと臨床免疫学の最新動向を、スペイン、バレンシアで開催される「EAACI Congress 2024」で網羅 http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 スペイン、バレンシア発, March 19, 2024 (GLOBE NEWSWIRE) --...
EAACI Congress 2024
Mengupas Kemajuan Terbaru dalam Alergi dan Imunologi Klinis pada Kongres EAACI 2024 di Valencia, Spanyol http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 VALENCIA, Spanyol, March 19, 2024 (GLOBE NEWSWIRE) -- Akademi Alergi dan Imunologi Klinis Eropa (EAACI)...
EAACI Congress 2024
報導於西班牙華倫西亞舉行的 EAACI Congress 2024(2024 年度歐洲過敏及臨床免疫學會大會)中,過敏症及臨床免疫學的最新動態 http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 華倫西亞,西班牙, March 19, 2024 (GLOBE NEWSWIRE) -- 來自全球 125 個國家及地區,會員人數逾 16,000 人的 European Academy of Allergy...
EAACI Congress 2024
在巴伦西亚, 西班牙举行的 2024 年欧洲变态反应与临床免疫学学会大会上报道变态反应和临床免疫学的最新发展动态 http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 巴伦西亚, 西班牙, March 19, 2024 (GLOBE NEWSWIRE) -- 欧洲变态反应与临床免疫学学会 (EAACI) 拥有来自 125 个国家/地区的 16,000...
Sema4_Logo2021_Primary_Gradient.png
Sema4 to Participate at Two Investor Conferences in June 2022
26 mai 2022 08h00 HE | Sema4
STAMFORD, Conn., May 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that company management will participate...
Sema4_Logo2021_Primary_Gradient.png
Sema4 Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 mai 2022 16h05 HE | Sema4
STAMFORD, Conn., May 04, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that, effective as of May 2, 2022, the...
Sema4_Logo2021_Primary_Gradient.png
Sema4 Announces the Completion of the GeneDx Acquisition and a Streamlined Leadership Structure to Accelerate Growth of its Diagnostic and Clinical Data Platforms
02 mai 2022 07h45 HE | Sema4
Acquisition creates an AI-driven advanced health intelligence company, now leveraging one of the largest genomic testing platforms in the U.S. Katherine Stueland, former President and CEO of GeneDx,...